Termination of transfusion dependence in beta-thalassemia: two-year experience with recombinant human erythropoietin.
Nişli
G
G
Kavakli
K
K
Aydinok
Y
Y
Oztop
S
S
Cetingül
N
N
D000293:Adolescent; D001803:Blood Transfusion; D002648:Child; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use; D017086:beta-Thalassemia / Q000628:therapy*
D011994:Recombinant Proteins; D004921:Erythropoietin